Trial NCT01629511

View at ClinicalTrials.gov 
Org. Study IDs: 2012-0249
Secondary IDs: 2012-0249 NCI-2018-01798 P30CA016672

Last trial update was posted on 2020-02-24

MeSH Interventions

Antilymphocyte Serum Busulfan Clofarabine Gemcitabine Lenograstim Methotrexate Tacrolimus Thymoglobulin

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Leukemia, Prolymphocytic

Other Conditions

Allogeneic Hematopoietic Stem Cell Transplantation Recipient Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Richter Syndrome

Stopping Reasons

N/A

Limitations And Caveats

Early termination leading to small number of subjects analyzed. This study never moved to Phase II, therefore was not analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID